Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP001319

Drug Information
NameAdenosine monophosphate
SynonymsFormycin 5'-phosphate hydrate; AMP (nucleotide); a-5mp; 67583-85-1; 162756-82-3; 2gmk; Muskeladenosin-phosphorsaeure; adenylate; 1H-Pyrazolo(4,3-d)pyrimidine, 7-amino-3-beta-D-ribofuranosyl-, 5'-(dihydrogen phosphate)-, hydrate; 8-Aminoadenosine 5'-monophosphate; Adenovite; Prestwick2_000356; Adenine polynucleotides; Adenosine 5'-(dihydrogen phosphate); Lycedan; Adenosine-5-phosphate; MolPort-003-987-006; BRN 0054612; NCGC00163319-01; DB00131; NCGC00163319-02; D02769; adenosine-monophosphate; Formycin A 5'-monophosphate hydrate; A5MP; 53624-78-5; Phosaden; nchembio.266-comp19; Adenosine phosphate [USAN:INN:BAN]; (S)-1-C-(7-Amino-1H-pyrazolo(4,3-d)pyrimidin-3-yl)-1,4-anhydro-D-ribitol, 5-(dihydrogen phosphate); MolPort-004-946-768; HSDB 3281; Adenosine-5'-monophosphate; Formycin 5'-monophosphate hydrate; Prestwick3_000356; CID15938965; Phosphentaside; Polyadenylic acids; ZINC03860156; 47287-97-8; NSC 20264; My-B-Den; Adenosine monophosphate; Fosfato de adenosina [INN-Spanish]; AMP; 61-19-8; Adenosine-5-monophosphate(2-); PAdo; ASMP; LS-15192; POLY A; adenosine 5'-phosphate; Adenyl; Phosphate d'adenosine [INN-French]; Muscle adenylic acid; bmse000005; Phosphate d'adenosine; Adenosine phosphate (USAN/INN); Adenylic acid (VAN); Prestwick0_000356; 1z6s; CHEMBL752; Adenyl (TN); 7gpb; C00020; CHEBI:456215; 9H-Purin-6-amine, 9-(5-O-phosphono-.beta.-D-ribofuranosyl)-; Adenosine-5'-monophosphate; 2vfk; 9H-purin-6-amine, 9-(5-O-phosphono-beta-D-ribofuranosyl)-; Adenosine phosphate [USAN:BAN:INN]; 34051-12-2; nchembio867-comp5; Adenosine-5'-monophosphoric acid; 2gsu; 5'-adenosine monophosphate; A0158; Fosfato de adenosina; Phosphaden; Adenosine-5-monophosphoric acid; Vitamin B8; Myoston; BPBio1_000497; 47286-65-7; 5'-Adenylic acid, 8-amino-; 5'-Adenylic acid, homopolymer; AMP dianion; AR-1H6048; Adenosine 5'-monophosphoric acid; Adenosine, mono(dihydrogen phosphate) (ester); BSPBio_000451; Adenosini phosphas [INN-Latin]; Cardiomone; Adenosine 5'-phosphoric acid; 24937-83-5; 5'-adenylic acid; 3dhv; 5'-AMP; 5'-Thio-5'-adenylic acid; Monophosphadenine; 5'-Deoxy-5'-thioadenosine 5'-monophosphate; Adenosini phosphas; 1pyg; 7-Amino-3-beta-D-ribofuranosyl-1H-pyrazolo(4,3-d)pyrimidine 5'-(dihydrogen phosphate) hydrate; adenosine-5'P; NSC-20264; AMP (VAN); 7A8E6D15-9136-44C1-88C9-E1A224638E56; Formycin 5'-phosphate; Prestwick1_000356; Adenosine Monophosphate (Amp); Adenosine-5-monophosphate dianion; Ergadenylic acid; 1ua4; SPBio_002372; CID6083; 2qrk; 4-26-00-03615 (Beilstein Handbook Reference); Ado5'P; AC1Q1ID5; CHEBI:16027; 8gpb; LS-129209; EINECS 200-500-0; adenosine phosphate; Muskeladenylsaeure; AC1L1LRL; 55036-25-4; [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate; adenosine-phosphate; GAMMA-ARSONO-BETA, GAMMA-METHYLENEADENOSINE-5'-DIPHOSPHATE; 13270-66-1; STOCK1N-70887; adenosine 5'-monophosphate; 697214-87-2; TL8003885; 5'-Adenylic acid, 5'-thio-; ADENOSINE-5'-PHOSPHATE; 2q8m; adenylic acid; 5'-O-phosphonoadenosine; 5'-O-phosphonatoadenosine
IndicationDietary shortage
[ICD9: 260-269   ICD10: E40-E46]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10
)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,2
0)/p-2/t4-,6-,7-,10-/m1/s1
InChIKeyUDMBCSSLTHHNCD-KQYNXXCUSA-L
Canonical SMILESC1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)COP(=O)([O-])[O-])O)O    
Isomeric SMILESC1=NC2=C(C(=N1)N)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O
Therapeutic ClassDietary supplement
CAS NumberCAS 61-19-8
FormulaC10H14N5O7P
PubChem Compound IDCID 15938965.
PubChem Substance IDSID 2142.
ChEBI16027;
SuperDrug ATC IDC01EB10
TargetAdenylate cyclase type 1Binder[2]
Ref 1Emerging drugs for chemotherapy-induced mucositis. Expert Opin Emerg Drugs. 2008 Sep;13(3):511-22. To Reference
Ref 2Ecto- and cytosolic 5'-nucleotidases in normal and AMP deaminase-deficient human skeletal muscle. Biol Chem. 2006 Jan;387(1):53-8. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543